Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - human normal immunoglobulin 5 g - powder and solvent for solution for infusion - 5 g - human polyvalent immunoglobulin 5000 mg - immunoglobulins, normal human, for intravascular adm.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - human normal immunoglobulin 10 g - powder and solvent for solution for infusion - 10 g - human polyvalent immunoglobulin 10000 mg - immunoglobulins, normal human, for intravascular adm.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baxalta innovations gmbh - human normal immunoglobulin 2,5 g - powder and solvent for solution for infusion - 2,5 g - human polyvalent immunoglobulin 2500 mg - immunoglobulins, normal human, for intravascular adm.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter - human immunoglobulin g - powder and solvent for solution for infusion - 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter - human immunoglobulin g - powder and solvent for solution for infusion - 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter - human immunoglobulin g - powder and solvent for solution for infusion - 50 mg/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter - human immunoglobulin g - powder and solvent for solution for infusion - 50 mg/ml

United States - English - NLM (National Library of Medicine)

takeda pharmaceuticals america, inc. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 mg in 1 ml - primary immunodeficiency (pi) gammagard s/d is indicated for the treatment of primary immunodeficiency (pi) associated with defects in humoral immunity, in adults and children two years and older. this includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, wiskott-aldrich syndrome, and severe combined immunodeficiencies.1,2,3 b-cell chronic lymphocytic leukemia (cll) gammagard s/d is indicated for prevention of bacterial infections in patients with hypogammaglobulinemia and/or recurrent bacterial infections associated with b-cell chronic lymphocytic leukemia (cll).4 idiopathic thrombocytopenic purpura (itp) gammagard s/d is indicated for the treatment of adult chronic idiopathic thrombocytopenic purpura to increase platelet count and to prevent and/or to control bleeding. kawasaki syndrome gammagard s/d is indicated for the prevention of coronary artery aneurysms associated with kawasaki syndrome in pediatric patients.5 gammagard s/d is contraindicated in patients wh

United States - English - NLM (National Library of Medicine)

baxalta us inc. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 mg in 1 ml - primary immunodeficiency (pi) gammagard s/d is indicated for the treatment of primary immunodeficiency (pi) associated with defects in humoral immunity, in adults and children two years and older. this includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, wiskott-aldrich syndrome, and severe combined immunodeficiencies.1,2,3 b-cell chronic lymphocytic leukemia (cll) gammagard s/d is indicated for prevention of bacterial infections in patients with hypogammaglobulinemia and/or recurrent bacterial infections associated with b-cell chronic lymphocytic leukemia (cll).4 idiopathic thrombocytopenic purpura (itp) gammagard s/d is indicated for the treatment of adult chronic idiopathic thrombocytopenic purpura to increase platelet count and to prevent and/or to control bleeding. kawasaki syndrome gammagard s/d is indicated for the prevention of coronary artery aneurysms associated with kawasaki syndrome in pediatric patients.5 - gammagard s/d is contraindicated in patients

Canada - English - Health Canada

takeda canada inc - immunoglobulin (human) - solution - 200mg - immunoglobulin (human) 200mg - serums